Pioglitazone HCl is an oral antidiabetic medication belonging to the thiazolidinedione (TZD) class, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. As an insulin sensitizer, it acts as a potent agonist for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma). By activating this receptor, it directly reduces insulin resistance in peripheral tissues and the liver, thereby enhancing glucose uptake and utilization. Additionally, Pioglitazone HCl helps improve lipid profiles by increasing HDL-C (“good” cholesterol) and reducing triglycerides, making it a valuable therapeutic option for managing the underlying metabolic dysfunction of type 2 diabetes.
Pioglitazone HCl 112529-15-4 ,Blood glucose reduction API
$200.00
Pioglitazone hydrochloride (marketed under the brand name Actos) is an oral thiazolidinedione (TZD) used to manage type 2 diabetes by improving insulin sensitivity and reducing hepatic glucose production.
Be the first to review “Pioglitazone HCl 112529-15-4 ,Blood glucose reduction API”
Reviews
There are no reviews yet.